A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria

Psychiatry Research - Neuroimaging

Volumn 148, Issue 2-3, 2006, Pages 185-193

  Jovanovic, Hristina ^a   Cerin, Åsta ^a   Karlsson, Per ^a   Lundberg, Johan ^a   Halldin, Christer ^a   Nordström, Anna Lena ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5HT1A; Gonadal hormones; PMDD; Positron emission tomography; Serotonin

Indexed keywords

CYCLOHEXANECARBONYL CHLORIDE C 11; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEX HORMONE; TRACER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLICULAR PHASE; HORMONE BINDING; HORMONE BLOOD LEVEL; HORMONE URINE LEVEL; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; OVULATION; POSITRON EMISSION TOMOGRAPHY; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; RAPHE NUCLEUS; RECEPTOR BINDING; SEROTONINERGIC SYSTEM;

ADULT; BRAIN; EMOTIONS; FEMALE; FOLLICULAR PHASE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUTEAL PHASE; MAGNETIC RESONANCE IMAGING; MENSTRUAL CYCLE; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PREMENSTRUAL SYNDROME; PYRIDINES; RAPHE NUCLEI; RECEPTOR, SEROTONIN, 5-HT1A; REFERENCE VALUES; SEROTONIN ANTAGONISTS;

EID: 33750966749     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2006.05.002     Document Type: Article

References (49)

1. American Psychiatric Association. Premenstrual dysphoric disorder. Diagnostic and Statistical Manual of Mental Disorders (1994), APA, Washington, DC
2. Angst J., Sellaro R., Merikangas K.R., and Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatrica Scandinavica 104 (2001) 110-116
3. Ashby Jr. C.R., Carr L.A., Cook C.L., Steptoe M.M., and Franks D.D. Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome. Journal of Neural Transmission. General Section 79 (1990) 41-50
4. Backstrom T., Sanders D., Leask R., Davidson D., Warner P., and Bancroft J. Mood, sexuality, hormones, and the menstrual cycle: II. Hormone levels and their relationship to the premenstrual syndrome. Psychosomatic Medicine 45 (1983) 503-507
5. Bancroft J., Cook A., Davidson D., Bennie J., and Goodwin G. Blunting of neuroendocrine responses to infusion of l-tryptophan in women with perimenstrual mood change. Psychological Medicine 21 (1991) 305-312
6. Baumann B., Bielau H., Krell D., Agelink M.W., Diekmann S., Wurthmann C., Trubner K., Bernstein H.G., Danos P., and Bogerts B. Circumscribed numerical deficit of dorsal raphe neurons in mood disorders. Psychological Medicine 32 (2002) 93-103
7. Bergstrom M., Boethius J., Eriksson L., Greitz T., Ribbe T., and Widen L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. Journal of Computer Assisted Tomography 5 (1981) 136-141
8. Biegon A., Bercovitz H., and Samuel D. Serotonin receptor concentration during the estrous cycle of the rat. Brain Research 187 (1980) 221-225
9. Cleare A.J., and Bond A.J. Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression. Psychopharmacology (Berl) 148 (2000) 344-349
10. Coccaro E.F., Gabriel S., and Siever L.J. Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans. Psychopharmacology Bulletin 26 (1990) 393-405
11. Coccaro E.F., Kavoussi R.J., and Hauger R.L. Physiological responses to d-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorder. International Clinical Psychopharmacology 10 (1995) 177-179
12. Davidson R.J., Lewis D.A., Alloy L.B., Amaral D.G., Bush G., Cohen J.D., Drevets W.C., Farah M.J., Kagan J., McClelland J.L., Nolen-Hoeksema S., and Peterson B.S. Neural and behavioral substrates of mood and mood regulation. Biological Psychiatry 52 (2002) 478-502
13. Dimmock P.W., Wyatt K.M., Jones P.W., and O'Brien P.M. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 356 (2000) 1131-1136
14. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., Huang Y., Gautier C., and Mathis C.M. PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry 46 (1999) 1375-1387
15. Eriksson E., Hedberg M.A., Andersch B., and Sundblad C. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12 (1995) 167-176
16. Farde L., Ito H., Swahn C.G., Pike V.W., and Halldin C. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. Journal of Nuclear Medicine 39 (1998) 1965-1971
17. Filicori M., Butler J.P., and Crowley Jr. W.F. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. Journal of Clinical Investigation 73 (1984) 1638-1647
18. Filicori M., Santoro N., Merriam G.R., and Crowley Jr. W.F. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. Journal of Clinical Endocrinolology and Metabolism 62 (1986) 1136-1144
19. FitzGerald M., Malone K.M., Li S., Harrison W.M., McBride P.A., Endicott J., Cooper T., and Mann J.J. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. American Journal of Psychiatry 154 (1997) 556-558
20. Fludder J.M., and Tonge S.R. Proceedings: variations in the concentrations of monoamines and their metabolites in eight regions of rat brain during the oestrous cycle: a basis for interactions between hormones and psychotropic drugs. Journal of Pharmacy and Pharmacology 27 (1975) (39 pp.)
21. Flugge G., Pfender D., Rudolph S., Jarry H., and Fuchs E. 5HT1A-receptor binding in the brain of cyclic and ovariectomized female rats. Journal of Neuroendocrinology 11 (1999) 243-249
22. Graze K.K., Nee J., and Endicott J. Premenstrual depression predicts future major depressive disorder. Acta Psychiatrica Scandinavica 81 (1990) 201-205
23. Gundlah C., Simon L.D., and Auerbach S.B. Differences in hypothalamic serotonin between estrous phases and gender: an in vivo microdialysis study. Brain Research 785 (1998) 91-96
24. 11C]WAY-100635 for PET. Neuroimage 8 (1998) 426-440
25. Gur R.C., Gunning-Dixon F., Bilker W.B., and Gur R.E. Sex differences in temporo-limbic and frontal brain volumes of healthy adults. Cerebral Cortex 12 (2002) 998-1003
26. Halbreich U. Premenstrual dysphoric disorders, anxiety, and depressions: vulnerability traits or comorbidity. Archive of General Psychiatry 52 (1995) 606
27. Halbreich U., and Endicott J. Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatrica Scandinavica 71 (1985) 331-338
28. Hall H., Lundkvist C., Halldin C., Farde L., Pike V.W., McCarron J.A., Fletcher A., Cliffe I.A., Barf T., Wikstrom H., and Sedvall G. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Research 745 (1997) 96-108
29. Harrison, W.M., Rabkin, J.G., Endicott, J., 1985. Psychiatric evaluation of premenstrual changes. Psychosomatics 26, 789-792, 795, 798-789.
30. Lammertsma A.A., and Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 4 (1996) 153-158
31. Landen M., and Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders?. Depression and Anxiety 17 (2003) 122-129
32. Maswood S., Truitt W., Hotema M., Caldarola-Pastuszka M., and Uphouse L. Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors. Brain Research 831 (1999) 146-154
33. Meltzer C.C., Drevets W.C., Price J.C., Mathis C.A., Lopresti B., Greer P.J., Villemagne V.L., Holt D., Mason N.S., Houck P.R., Reynolds III C.F., and DeKosky S.T. Gender-specific aging effects on the serotonin 1A receptor. Brain Research 895 (2001) 9-17
34. Moses E.L., Drevets W.C., Smith G., Mathis C.A., Kalro B.N., Butters M.A., Leondires M.P., Greer P.J., Lopresti B., Loucks T.L., and Berga S.L. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biological Psychiatry 48 (2000) 854-860
35. 11C]WAY-100635 in humans: comparison of arterial and reference tissue input functions. Journal of Cerebral Blood Flow and Metabolism 20 (2000) 1111-1133
36. Parsey R.V., Oquendo M.A., Simpson N.R., Ogden R.T., Van Heertum R., Arango V., and Mann J.J. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Research 954 (2002) 173-182
37. Rapkin A.J., Buckman T.D., Sutphin M.S., Chang L.C., and Reading A.E. Platelet monoamine oxidase B activity in women with premenstrual syndrome. American Journal of Obstetrics and Gynecology 159 (1988) 1536-1540
38. Roland P.E., and Zilles K. Brain atlases-a new research tool. Trends in Neuroscience 17 (1994) 458-467
39. Rossmanith W.G., Laughlin G.A., Mortola J.F., Johnson M.L., Veldhuis J.D., and Yen S.S. Pulsatile cosecretion of estradiol and progesterone by the midluteal phase corpus luteum: temporal link to luteinizing hormone pulses. Journal of Clinical Endocrinology and Metabolism 70 (1990) 990-995
40. Rubinow D.R., Hoban M.C., Grover G.N., Galloway D.S., Roy-Byrne P., Andersen R., and Merriam G.R. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. American Journal of Obstetrics and Gynecology 158 (1988) 5-11
41. 11C]WAY-100635: effects of depression and antidepressant treatment. Archive of General Psychiatry 57 (2000) 174-180
42. Schmidt P.J., Nieman L.K., Danaceau M.A., Adams L.F., and Rubinow D.R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. New England Journal of Medicine 338 (1998) 209-216
43. Slater P., Doyle C.A., and Deakin J.F. Abnormal persistence of cerebellar serotonin-1A receptors in schizophrenia suggests failure to regress in neonates. Journal of Neural Transmission 105 (1998) 305-315
44. Smith C.E., Ware C.J., and Cowen P.J. Pindolol decreases prolactin and growth hormone responses to intravenous l-tryptophan. Psychopharmacology 103 (1991) 140-142
45. Steege J.F., Stout A.L., Knight D.L., and Nemeroff C.B. Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome. American Journal of Obstetrics and Gynecology 167 (1992) 168-172
46. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., and Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. Journal of Neuroscience 18 (1998) 7394-7401
47. Wienhard K., Dahlbom M., Eriksson L., Michel C., Bruckbauer T., Pietrzyk U., and Heiss W.D. The ECAT EXACT HR: performance of a new high resolution positron scanner. Journal of Computer Assisted Tomography 18 (1994) 110-118
48. Yatham L.N. Is 5HT1A receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study. Canadian Journal of Psychiatry 38 (1993) 662-664
49. Yonkers K.A., Halbreich U., Freeman E., Brown C., Endicott J., Frank E., Parry B., Pearlstein T., Severino S., Stout A., Stone A., and Harrison W. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. Journal of the American Medical Association 278 (1997) 983-988